This Whirlpool Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
Amphastar Pharmaceuticals, Inc AMPH
$18.42
▲ +1.43%
(+$0.26)
Open
$18.26
Prev Close
$18.16
Day Range
$17.93 – $18.44
52W Range
$16.65 – $31.26
Market Cap
$811.75M
P/E (TTM)
10.25
Beta
0.93
EPS (TTM)
$1.67
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2014-06-25 |
| Shares Out. | 44,090,000 |
| Website | amphastar.com/ ↗ |
| Phone | 18004831140 |
Amphastar Pharmaceuticals, Inc is a publicly traded company under the ticker symbol AMPH on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
13 analysts (2026-05-01)
📰 Latest News for AMPH
Wells Fargo Downgrades Amphastar Pharma to Equal-Weight, Lowers Price Target to $19
Amphastar Pharmaceuticals, Inc. (AMPH) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Transcript : Amphastar Pharmaceuticals, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 03
Amphastar Pharmaceuticals : 2026 Bank of America Health Care Conference
Piper Sandler Reiterates Neutral on Amphastar Pharma, Lowers Price Target to $21